{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:55:14Z","timestamp":1792684514523,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00257","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T04:19:15Z","timestamp":1527049155000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology"],"prefix":"10.3389","volume":"9","author":[{"given":"Kendal","family":"McCulloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Huesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Litherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Crilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Hultin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1042\/bj3200939","article-title":"Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases","volume":"320","author":"Belham","year":"1996","journal-title":"Biochem J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1074\/jbc.272.7.4043","article-title":"Interactions of mast cell tryptase with thrombin receptors and PAR-2","volume":"272","author":"Molino","year":"1997","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/ATVBAHA.112.300474","article-title":"Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function","volume":"33","author":"Kuckleburg","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26333","DOI":"10.1074\/jbc.M002941200","article-title":"Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates","volume":"275","author":"Takeuchi","year":"2000","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/89945","article-title":"Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway","volume":"7","author":"Vergnolle","year":"2001","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature22309","article-title":"Structural insight into allosteric modulation of protease-activated receptor 2","volume":"545","author":"Cheng","year":"2017","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.berh.2008.07.001","article-title":"Epidemiology of rheumatic musculoskeletal disorders in the developing world","volume":"22","author":"Chopra","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B11","first-page":"1607","article-title":"Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice","volume":"149","author":"M\u00fcller-Ladner","year":"1996","journal-title":"Am J Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/ar2110","article-title":"Cells of the synovium in rheumatoid arthritis. Osteoclasts","volume":"9","author":"Schett","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/JCI16913","article-title":"Essential role for proteinase-activated receptor-2 in arthritis","volume":"111","author":"Ferrell","year":"2003","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/annrheumdis-2011-200869","article-title":"Immunomodulatory role of proteinase-activated receptor-2","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/art.22423","article-title":"Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist","volume":"56","author":"Kelso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/annrheumdis-2011-200703","article-title":"PAR2 expression in peripheral blood monocytes of patients with rheumatoid arthritis","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1189\/jlb.0704422","article-title":"Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1{beta}","volume":"78","author":"Johansson","year":"2005","journal-title":"J Leukoc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1753425913479984","article-title":"Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function","volume":"19","author":"Steven","year":"2013","journal-title":"Innate Immun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","article-title":"Phenotype, function, and differentiation potential of human monocyte subsets","volume":"12","author":"Boyette","year":"2017","journal-title":"PLoS One"},{"key":"B21","first-page":"644","article-title":"Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta","volume":"23","author":"Ainola","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1172\/JCI200522263","article-title":"The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth","volume":"115","author":"Rhee","year":"2005","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.4049\/jimmunol.0904068","article-title":"Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function","volume":"184","author":"Sabeh","year":"2010","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI30765","article-title":"Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair","volume":"117","author":"Little","year":"2007","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ncprheum0727","article-title":"Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/ard.2007.086348","article-title":"Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis","volume":"68","author":"G\u00fcler-Y\u00fcksel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B28","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","article-title":"Impact of inflammation on the osteoblast in rheumatic diseases","volume":"12","author":"Baum","year":"2014","journal-title":"Curr Osteoporos Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S8756-3282(99)00237-9","article-title":"Expression of protease-activated receptor-2 by osteoblasts","volume":"26","author":"Abraham","year":"2000","journal-title":"Bone"},{"key":"B32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1359\/JBMR.0301248","article-title":"Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation","volume":"19","author":"Smith","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.bone.2011.11.023","article-title":"Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair","volume":"50","author":"Georgy","year":"2012","journal-title":"Bone"},{"key":"B34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s10067-006-0240-3","article-title":"The burden of musculoskeletal disease \u2013 a global perspective","volume":"25","author":"Brooks","year":"2006","journal-title":"Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/14397595.2013.854046","article-title":"Quality of life and self-reported disability in patients with knee osteoarthritis","volume":"24","author":"Alkan","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta12260","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip","volume":"12","author":"de Verteuil","year":"2008","journal-title":"Health Technol Assess"},{"key":"B37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J Cell Physiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1136\/ard.2004.025270","article-title":"Synovial tissue inflammation in early and late osteoarthritis","volume":"64","author":"Benito","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00296-011-2102-9","article-title":"Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis","volume":"32","author":"Tindell","year":"2012","journal-title":"Rheumatol Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1053\/berh.2001.0195","article-title":"Metalloproteases and inhibitors in arthritic diseases","volume":"15","author":"Martel-Pelletier","year":"2001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B42","first-page":"2199","article-title":"Etiopathogenesis of osteoarthritis","volume-title":"Arthritis and Allied Conditions. A Textbook of Rheumatology","author":"Martel-Pelletier","year":"2005"},{"key":"B43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mott","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.joca.2006.04.015","article-title":"Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1\u03b2, TNF-\u03b1 and TGF-\u03b2","volume":"14","author":"Xiang","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"B45","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1186\/ar2329","article-title":"Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study","volume":"9","author":"Boileau","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14728222.12.1.1","article-title":"Metalloproteases as potential therapeutic targets in arthritis treatment","volume":"12","author":"Rowan","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3899\/jrheum.080346","article-title":"The interleukin 1beta pathway in the pathogenesis of osteoarthritis","volume":"35","author":"Daheshia","year":"2008","journal-title":"J Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1136\/ard.2010.130336","article-title":"Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis","volume":"69","author":"Ferrell","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2015-208268","article-title":"Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology","volume":"75","author":"Huesa","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3899\/jrheum.100710","article-title":"Proteinase-activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: a novel target in joint degradation","volume":"38","author":"Amiable","year":"2011","journal-title":"J Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/art.38876","article-title":"Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms","volume":"66","author":"Jackson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.joca.2003.09.007","article-title":"Subchondral bone changes in hand and knee osteoarthritis detected by radiography","volume":"12","author":"Buckland-Wright","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"B53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/keh411","article-title":"Osteophytes and progression of knee osteoarthritis","volume":"44","author":"Felson","year":"2005","journal-title":"Rheumatology (Oxford)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T04:19:20Z","timestamp":1527049160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":53,"alternative-id":["10.3389\/fendo.2018.00257"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00257","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"article-number":"257"}}